pirfenidone
Anti-fibrotic and anti-inflammatory properties, modulates TGF-β and TNF-α
Guo Z, Chen S, Dong S et al.
Gholamrezaei SK, Samet M, Amelshahbaz AP et al.
Ruenwilai P, Tajarernmuang P, Chattipakorn SC et al.
Lee T, Lim YJ, Li AY et al.
Maeda R, Inomata M, Hazemoto T et al.
This drug has been validated in the following preclinical models: